Tower Research Capital LLC (Trc) Immucell Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Immucell Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,116 shares of ICCC stock, worth $3,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,116

Previous 1,767 36.84%

Holding current value

$3,950

Previous $8,000 50.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.53 - $4.46 $2,298 - $2,903	-651 Reduced 36.84%	1,116 $4,000
Q2 2024 Aug 13, 2024	SELL	$4.18 - $5.48 $986 - $1,293	-236 Reduced 11.78%	1,767 $8,000
Q1 2024 May 15, 2024	SELL	$4.73 - $5.47 $288 - $333	-61 Reduced 2.96%	2,003 $10,000
Q4 2023 Feb 13, 2024	BUY	$4.45 - $5.47 $1,909 - $2,346	429 Added 26.24%	2,064 $10,000
Q3 2023 Nov 14, 2023	SELL	$4.53 - $5.61 $12,534 - $15,522	-2,767 Reduced 62.86%	1,635 $8,000
Q2 2023 Aug 14, 2023	BUY	$4.64 - $5.98 $9,590 - $12,360	2,067 Added 88.52%	4,402 $22,000
Q1 2023 May 09, 2023	BUY	$4.85 - $7.84 $5,136 - $8,302	1,059 Added 82.99%	2,335 $12,000
Q4 2022 Feb 10, 2023	BUY	$6.09 - $8.25 $7,770 - $10,527	1,276 New	1,276 $8,000
Q2 2022 Aug 15, 2022	BUY	$7.7 - $10.71 $1,178 - $1,638	153 New	153 $1,000
Q1 2022 May 12, 2022	SELL	$8.0 - $10.06 $800 - $1,006	-100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.0 - $9.74 $800 - $974	100 New	100 $1,000
Q3 2021 Nov 15, 2021	SELL	$8.54 - $10.24 $3,638 - $4,362	-426 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.5 - $10.95 $2,720 - $3,504	-320 Reduced 42.9%	426 $4,000
Q1 2021 May 17, 2021	BUY	$5.98 - $11.88 $3,372 - $6,700	564 Added 309.89%	746 $7,000
Q4 2020 Feb 16, 2021	SELL	$5.21 - $6.42 $651 - $802	-125 Reduced 40.72%	182 $1,000
Q3 2020 Nov 16, 2020	BUY	$4.98 - $6.35 $1,528 - $1,949	307 New	307 $2,000
Q1 2020 May 15, 2020	SELL	$3.79 - $5.92 $6,719 - $10,496	-1,773 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$4.81 - $5.57 $4,502 - $5,213	936 Added 111.83%	1,773 $9,000
Q3 2019 Nov 05, 2019	BUY	$5.15 - $6.55 $4,001 - $5,089	777 Added 1295.0%	837 $5,000
Q2 2019 Aug 13, 2019	SELL	$5.89 - $6.86 $3,857 - $4,493	-655 Reduced 91.61%	60 $0
Q1 2019 May 14, 2019	BUY	$5.91 - $8.09 $1,022 - $1,399	173 Added 31.92%	715 $5,000
Q4 2018 Feb 14, 2019	BUY	$6.4 - $9.03 $1,580 - $2,230	247 Added 83.73%	542 $4,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.99 $825 - $1,141	127 Added 75.6%	295 $2,000
Q2 2018 Aug 15, 2018	BUY	$6.75 - $8.28 $1,134 - $1,391	168 New	168 $1,000
Q1 2018 May 15, 2018	SELL	$6.93 - $8.27 $367 - $438	-53 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$6.74 - $9.23 $357 - $489	53	53 $0

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.15M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $27.4M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Immucell Corp Transaction History